Comments

Novo Nordisk

Q: What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

NVONYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$85.34

1.311.56%

At close: -

$85.15

-0.19-0.22%

After Hours: 6:50 PM EDT

Q4 2024 Earnings in 6 days from now on Wed Feb 5th, before the market open

Conference call scheduled in 6 days at 7:00 AM Click to view the webcast

Novo Nordisk (NVO) Forecast

News Earnings Novo Nordisk (NVO) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Good

Technicals Analysis

0100

Financials Analysis

0100

Novo Nordisk (NYSE:NVO) Stock Quotes, Forecast and News Summary

Novo Nordisk Stock (NYSE: NVO) stock price, news, charts, stock research, profile.

Open	$84.60
Close	$85.34
Volume / Avg.	5.80M / 8.01M
Day Range	$83.94 - $86.47
52 Wk Range	78.17 - 148.15
Market Cap	$378.03B
P/E Ratio	28.32
Dividend Yield	1.72%
Exchange	NYSE
RSI	45
Short Interest	-
Days to Cover	1

Recent News

RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders

Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people.

Anthony Noto

Ozempic Receives FDA Approval To Treat Kidney Disease

The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease in patients who also have type 2 diabetes.

Erica Kollmann

How Ozempic And Legal Weed Are Changing What America Eats

Ozempic curbs appetites, while cannabis legalization fuels munchies. Explore their public health impacts.

Javier Hasse

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$84.60
Close	$85.34
Volume / Avg.	5.80M / 8.01M
Day Range	$83.94 - $86.47
52 Wk Range	78.17 - 148.15
Market Cap	$378.03B
P/E Ratio	28.32
Dividend Yield	1.72%
Exchange	NYSE
RSI	45
Short Interest	-
Days to Cover	1

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Novo Nordisk (NVO) stock?

You can purchase shares of Novo Nordisk (NYSE:NVO) through any online brokerage.

View our list of the best stock brokerages

Who are Novo Nordisk (NVO) competitors?

There are no as such competitors for Novo Nordisk.

What is the forecast, or price target, for Novo Nordisk (NVO) stock?

Novo Nordisk has a consensus price target of $116.57.

What is the current price for Novo Nordisk (NVO)?

The stock price for Novo Nordisk (NYSE: NVO) is $85.15 last updated January 30, 2025 at 6:50 PM EST.

Does Novo Nordisk (NVO) pay a dividend?

A quarterly cash dividend of 2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 2, 2012 to stockholders of record on March 22, 2012.

When is Novo Nordisk (NYSE:NVO) reporting earnings?

Novo Nordisk’s Q4 earnings are confirmed for Wednesday, February 5, 2025.

Is Novo Nordisk (NVO) going to split?

There is no upcoming split for Novo Nordisk.

What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.